In addition, DRAM1 expression decreased in human colon cancer cells treated with anti-PD-1 nivolumab, suggesting that DRAM1 is a pro-cancer-associated autophagy gene (53), which is consistent with the results of this study. The gene discussed is DRAM1; the disease is colonic neoplasm.